Publications by authors named "Radhakrishnan Vs"

Claim this Profile
I
Investigating inhibitory effect of sterol targeting compounds against B. anthracis: Membrane microdomain a probable target.
Vikas Kumar Somani, Somya Aggarwal, V S Radhakrishnan, Tulika Prasad, Rakesh Bhatnagar

Res Microbiol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody-Based Therapies for the Treatment of Hodgkin Lymphoma in Older Patients.
Vivek S Radhakrishnan, Peter W M Johnson

J Clin Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Draft genome sequences of multi-drug-resistant strains isolated from ulcerative colitis patients.
Asha Yadav, Pratik Balwant Shinde, Mahesh S Dhar, Kalaiarasan Ponnusamy, Robin Marwal, RadhaKrishnan Vs

Microbiol Resour Announc· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gut colonization with antibiotic-resistant Escherichia coli pathobionts leads to disease severity in ulcerative colitis.
Asha Yadav, Pratik Balwant Shinde, Hari Mohan, Mahesh S Dhar, Kalaiarasan Ponnusamy

Int J Antimicrob Agents· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanistic Insights into Cellular and Molecular Targets of Zinc Oxide Quantum Dots (ZnO QDs) in Fungal Pathogen, : One Drug Multi-Targeted Therapeutic Approach.
Preeti Chand, Kritika Narula, Radhakrishnan Vs, Shubham Sharma, Sangeeta Kumari

ACS Infect Dis· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimeric Antigen Receptor T-cell based cellular therapies for cancer: An introduction and Indian perspective.
Reena J Rathod, Reghu K Sukumaran, Neelam Kedia, Jeevan Kumar, Reena Nair

Indian J Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody based therapies in Hodgkin lymphoma.
Vivek S Radhakrishnan, Jemma Longley, Peter W M Johnson

Cancer Treat Rev· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bispecific antibodies in indolent B-cell lymphomas.
Vivek S Radhakrishnan, Andrew J Davies

Front Immunol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage Using Polatuzumab Vedotin Based Therapy in Relapsed Refractory Large B-Cell Lymphomas: Early Experience from a Real-World Middle-Income Setting Using Named-Patient Compassionate Access Program.
V S Radhakrishnan, R Pincha, V Raina, J K Garg, A Nag

Indian J Hematol Blood Transfus· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral T-Cell Lymphoma, Hemophagocytic Lymphohistiocytosis, and XIAP Gene Mutations: Getting the Treatment Right!
Vinay Anand Guntiboina, Vivek S Radhakrishnan, Jeevan Kumar, Saurabh J Bhave, Sushant Vinarkar

Clin Lymphoma Myeloma Leuk· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mantle cell lymphoma: A clinical review of the changing treatment paradigms with the advent of novel therapies, and an insight into Indian data.
Vivek Sulekha Radhakrishnan, Padmaja Lokireddy, Mayur Parihar, Prashanth Srirangapattana Prakash, Hari Menon

Cancer Rep (Hoboken)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary Central Nervous System Lymphoma: Long-Term Treatment Outcomes and Cost-Analysis from a Retrospective Study of High-Dose Methotrexate Based Chemoimmunotherapy and Reduced Dose Radiation Therapy Approach.
Radhakrishnan Vs, Podder D, Mukherjee H, Mandal P, Achari R

Indian J Hematol Blood Transfus· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precursor B-cell acute lymphoblastic leukaemia-a global view.
Andrea Biondi, Valentino Conter, Mammen Chandy, Primus Ewald, Marie Lucia de Martino Lee

Br J Haematol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spatio-temporal dynamics of intra-host variability in SARS-CoV-2 genomes.
Ankit K Pathak, Gyan Prakash Mishra, Bharathram Uppili, Safal Walia, Saman Fatihi

Nucleic Acids Res· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relapsed Refractory Hodgkin Lymphoma and Brentuximab Vedotin-Bendamustine Combination Therapy as a Bridge to Transplantation: Real-World Evidence From a Middle-Income Setting and Literature Review.
Vivek S Radhakrishnan, Rajat Bajaj, Vasundhara Raina, Jeevan Kumar, Saurabh J Bhave

Front Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion.
Petra Mlcochova, Steven A Kemp, Mahesh Shanker Dhar, Guido Papa, Bo Meng

Nature· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic characterization and epidemiology of an emerging SARS-CoV-2 variant in Delhi, India.
Mahesh S Dhar, Robin Marwal, Radhakrishnan Vs, Kalaiarasan Ponnusamy, Bani Jolly

Science· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Quality and Efficacy of Apheresis Platelets Stored in Platelet Additive Solution Vis a Vis Plasma.
Debapriya Basu, Sabita Basu, Vivek S Radhakrishnan, Sanjay Bhattacharya, Subhosmito Chakraborty

Indian J Hematol Blood Transfus· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab biosimilars for B-cell lymphomas: a decade of real-world experience from India.
Reena Nair, Vivek S Radhakrishnan, Mohandas K Mallath

Lancet Haematol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of diffuse large B-cell lymphoma in elderly patients-real-world experience from a middle-income country setting.
Chandrayee Sarker, Vivek S Radhakrishnan, Payal Mandal, Jeevan Kumar, Saurabh Bhave

Ecancermedicalscience· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relapsed plasmablastic lymphoma in a HIV-negative patient: Pushing the envelope.
Manthan Kathrotiya, Vivek S Radhakrishnan, Saurabh J Bhave, Jeevan Kumar, Mita Roychowdhury

Clin Case Rep· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic Review of the Burden and Treatment Patterns of Adult and Adolescent Acute Lymphoblastic Leukemia in India: Comprehending the Challenges in an Emerging Economy.
Vivek S Radhakrishnan, Narendra Agrawal, Bhausaheb Bagal, Ishan Patel

Clin Lymphoma Myeloma Leuk· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoxic Transformation of Immune Cell Metabolism Within the Microenvironment of Oral Cancers.
Amrita Chaudhary, Swarnendu Bag, Neeraj Arora, Vivek S Radhakrishnan, Deepak Mishra

Front Oral Health· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 and haematology services in a cancer centre from a middle-income country: adapting service delivery, balancing the known and unknown during the pandemic.
Vivek S Radhakrishnan, Reghu K Sukumaran Nair, Gaurav Goel, Venkatraman Ramanan, Mammen Chandy

Ecancermedicalscience· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HSCT Guidelines for Transplant Practices During the COVID-19 Pandemic in India ISBMT DOCUMENT Version1.0.
Sharat Damodar, Vivek S Radhakrishnan, Joseph John M, Pankaj Malhotra, Reetu Jain

Blood Cell Ther· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis